News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Mark A. Heise, PhD

Articles by Mark A. Heise, PhD

Reduction in Use of Healthcare Services With Combination Sulfonylurea and Rosiglitazone: Findings From the Rosiglitazone Early vs SULfonylurea Titration (RESULT) Study

ByWilliam H. Herman, MD, MPH,Riad G. Dirani, PhD,Ruslan Horblyuk, MBA,M. Colleen O'Neill, BSc,Barbara Kravitz, MS,Mark A. Heise, PhD,Alan Bakst, PharmD, MBA,Martin I. Freed, MD,the RESULT St

April 1st 2005

Latest Updated Articles

Reduction in Use of Healthcare Services With Combination Sulfonylurea and Rosiglitazone: Findings From the Rosiglitazone Early vs SULfonylurea Titration (RESULT) Study
Published: April 1st 2005 | Updated:

Trending on AJMC

Trump Terminates Hundreds of SAMHSA Grants, Threatening Mental Health, Addiction Services Nationwide

ICHRA Growth Could Reshape Marketplace Risk Pools and Widen Access Disparities: Matthew McGough

CenterWell Pharmacy Expands Access to Obesity Medications Through Employer Program: Aleata Postell

Trump Announces “The Great Healthcare Plan,” Proposing Direct Payments, Price Transparency, Insurance Reform

Teclistamab-Daratumumab Outperforms Standard of Care for R/R Multiple Myeloma

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.